FDA inspection
Lilly France S.A.S.: FDA inspection ending Sep 29, 2023
FDA inspection 1299456 · Voluntary Action Indicated (VAI) · Fegersheim
Key facts
| Inspection ID | 1299456 |
|---|---|
| Firm | Lilly France S.A.S. |
| FEI number | 3002807475 |
| Address | Zone Dactivite Centre De Production, 2 Rue Du Colonel Lilly |
| City | Fegersheim |
| Country | France |
| Fiscal year | 2023 |
| Inspection end date | Sep 29, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data